Consolidated Statement Of Financial Position

Astellas Pharma Inc. - Filing #7577637

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
Consolidated statement of financial position
Statement of financial position
Assets
Current assets
Cash and cash equivalents
381,816,000,000 JPY
315,986,000,000 JPY
350,213,000,000 JPY
326,128,000,000 JPY
Inventories
163,221,000,000 JPY
153,072,000,000 JPY
Other financial assets
31,480,000,000 JPY
21,297,000,000 JPY
Other current assets
31,864,000,000 JPY
28,997,000,000 JPY
Current assets other than assets held for sale
1,071,325,000,000 JPY
923,354,000,000 JPY
Assets held for sale
1,268,000,000 JPY
JPY
Current assets
1,072,593,000,000 JPY
923,354,000,000 JPY
Non-current assets
Property, plant and equipment
269,106,000,000 JPY
269,044,000,000 JPY
Goodwill
324,068,000,000 JPY
303,030,000,000 JPY
Intangible assets
616,538,000,000 JPY
623,431,000,000 JPY
Investments accounted for using equity method
12,601,000,000 JPY
10,035,000,000 JPY
Other financial assets
90,102,000,000 JPY
91,844,000,000 JPY
Deferred tax assets
93,225,000,000 JPY
72,331,000,000 JPY
Other non-current assets
10,910,000,000 JPY
9,531,000,000 JPY
Non-current assets
1,441,355,000,000 JPY
1,409,041,000,000 JPY
Assets
2,513,948,000,000 JPY
2,332,395,000,000 JPY
Liabilities and equity
Liabilities
Current liabilities
Other financial liabilities
180,413,000,000 JPY
184,964,000,000 JPY
Income taxes payable
18,449,000,000 JPY
32,388,000,000 JPY
Provisions
12,613,000,000 JPY
16,570,000,000 JPY
Other current liabilities
360,196,000,000 JPY
322,751,000,000 JPY
Current liabilities
705,905,000,000 JPY
687,411,000,000 JPY
Non-current liabilities
Other financial liabilities
148,738,000,000 JPY
95,886,000,000 JPY
Retirement benefit liability
37,092,000,000 JPY
37,226,000,000 JPY
Provisions
4,041,000,000 JPY
5,831,000,000 JPY
Deferred tax liabilities
6,033,000,000 JPY
5,823,000,000 JPY
Other non-current liabilities
37,337,000,000 JPY
39,234,000,000 JPY
Non-current liabilities
237,619,000,000 JPY
184,676,000,000 JPY
Liabilities
943,524,000,000 JPY
872,087,000,000 JPY
Equity
Equity attributable to owners of parent
Share capital
103,001,000,000 JPY
103,001,000,000 JPY
Capital surplus
180,591,000,000 JPY
179,467,000,000 JPY
Retained earnings
996,246,000,000 JPY
944,261,000,000 JPY
Treasury shares
-23,020,000,000 JPY
-13,934,000,000 JPY
Other components of equity
313,607,000,000 JPY
247,512,000,000 JPY
Equity attributable to owners of parent
1,570,424,000,000 JPY
1,460,308,000,000 JPY
Equity
1,570,424,000,000 JPY
JPY
601,000,000 JPY
-23,020,000,000 JPY
103,001,000,000 JPY
1,570,424,000,000 JPY
180,591,000,000 JPY
302,005,000,000 JPY
313,607,000,000 JPY
996,246,000,000 JPY
11,002,000,000 JPY
1,460,308,000,000 JPY
-13,934,000,000 JPY
13,261,000,000 JPY
630,000,000 JPY
247,512,000,000 JPY
944,261,000,000 JPY
103,001,000,000 JPY
1,460,308,000,000 JPY
179,467,000,000 JPY
233,621,000,000 JPY
JPY
103,001,000,000 JPY
1,466,291,000,000 JPY
179,042,000,000 JPY
180,783,000,000 JPY
JPY
679,000,000 JPY
1,466,291,000,000 JPY
-15,520,000,000 JPY
18,666,000,000 JPY
200,129,000,000 JPY
999,640,000,000 JPY
1,386,115,000,000 JPY
745,000,000 JPY
103,001,000,000 JPY
1,386,115,000,000 JPY
-15,377,000,000 JPY
147,024,000,000 JPY
167,373,000,000 JPY
177,830,000,000 JPY
953,289,000,000 JPY
JPY
19,604,000,000 JPY
Liabilities and equity
2,513,948,000,000 JPY
2,332,395,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.